Abstract: This research work introduces a clustering-based in-place sorting algorithm, cluster sort. It is designed in such a way that it improves sorting efficiency by using data locality. It works ...

If you remember the film “The Big Short” (or, more likely, get served 60-second clips of it regularly on YouTube Shorts), then you’ll probably remember the term “credit default swap.” It’s the tool ...

Oracle’s second-quarter earnings report underlined the fragility of the AI trade in the second half of 2025. It doesn’t take much bad news from one company to take down the whole industry the next day ...

For almost as long as the artificial intelligence boom has been in full swing, there have been warnings of a speculative bubble that could rival the dot-com craze of the late 1990s that ended in a ...

It wasn’t too long ago that the mere mention of “artificial intelligence” in a corporate press release would trigger an upside move for the stock.

On Tuesday, Alphabet CEO Sundar Pichai warned of “irrationality” in the AI market, telling the BBC in an interview, “I think no company is going to be immune, including us.” His comments arrive as ...

Forbes contributors publish independent expert analyses and insights. Jason Alan Snyder is a technologist covering AI and innovation. The AI “bubble” narrative persists because people are diagnosing ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Theron Mohamed Every time Theron publishes a story, you’ll get an alert straight to your inbox!

He posted a chart showing how stocks peaked before capital spending did in past investment booms. Burry shared a meme from "The Lord of the Rings," suggesting investors are dangerously complacent.

NORFOLK, Va. — For the fifth year, Old Dominion University is going all out for its Public Arts Festival, and this year, it's all about bubbles! BUBBLE FEST features “larger-than-life” bubble ...

LONDON, Nov 6 (Reuters) - Bubble or bonanza? AI could be both. Artificial intelligence may well be the future of business and the wider economy, yet the sky-high stock prices it's generating may still ...

Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...